Sonnet BioTherapeutic News

Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Nov 4 22:04

Sonnet BioTherapeutic | S-1: General form for registration of securities under the Securities Act of 1933

Oct 28 21:04

Sonnet BioTherapeutic | 8-K: Current report

Oct 17 20:55

Sonnet BioTherapeutic | 8-K: Current report

Oct 9 21:01

Sonnet BioTherapeutic | 8-K: Current report

Sep 30 20:33

Sonnet BioTherapeutic | 8-K: Current report

Sep 18 20:37

Sonnet BioTherapeutic | 8-K: Current report

Sep 13 05:19

Sonnet BioTherapeutic | 8-K: Current report

Sep 10 04:11

Sonnet BioTherapeutic | 8-K: Current report

Aug 30 20:32

Sonnet BioTherapeutic | ARS: Annual Report to Security Holders

Aug 20 05:33

Sonnet BioTherapeutic | DEF 14A: Definitive information statements

Aug 20 05:28

Sonnet BioTherapeutic | 8-K: Current report

Aug 19 20:52

Sonnet BioTherapeutic | 10-Q: Q3 2024 Earnings Report

Aug 14 20:49

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Aug 14 20:44

Sonnet BioTherapeutic | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Aug 10 05:33

Sonnet BioTherapeutic | 8-K: Current report

Aug 10 04:08

Sonnet BioTherapeutic | 8-K: Current report

Jul 24 20:39

Sonnet BioTherapeutic | EFFECT: Others

Jul 16 18:02

Sonnet BioTherapeutic | 424B3: Prospectus

Jul 16 05:10

Sonnet BioTherapeutic | CORRESP: CORRESP

Jul 12 00:42